Global Human Serum Albumin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Human Serum Albumin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
Human Serum Albumin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Serum Albumin market is projected to reach US$ 8367.2 million in 2034, increasing from US$ 5109.6 million in 2022, with the CAGR of 7.3% during the period of 2024 to 2034. Demand from Therapeutics and Excipient are the major drivers for the industry.
The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%. In terms of its product type, human serum albumin with 20-25% concentration holds the major market share with 90%, while 5% concentration accounts for a smaller share. In terms of its application, therapeutic is its top application area, accounting for 80% of the market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Serum Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Segment by Type
20-25% Concentrations
5% Concentrations
Therapeutics
Excipient
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Human Serum Albumin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Serum Albumin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Serum Albumin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Serum Albumin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Serum Albumin introduction, etc. Human Serum Albumin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Human Serum Albumin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Human Serum Albumin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Serum Albumin market is projected to reach US$ 8367.2 million in 2034, increasing from US$ 5109.6 million in 2022, with the CAGR of 7.3% during the period of 2024 to 2034. Demand from Therapeutics and Excipient are the major drivers for the industry.
The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%. In terms of its product type, human serum albumin with 20-25% concentration holds the major market share with 90%, while 5% concentration accounts for a smaller share. In terms of its application, therapeutic is its top application area, accounting for 80% of the market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Serum Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Segment by Type
20-25% Concentrations
5% Concentrations
Segment by Application
Therapeutics
Excipient
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Human Serum Albumin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Serum Albumin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Serum Albumin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Serum Albumin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Serum Albumin introduction, etc. Human Serum Albumin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Human Serum Albumin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.